Delivery Order SPE2DB20D2104-SPE2DB24FT57R
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,088.94 firm fixed-price delivery order covers the supply of 4558887099 - SAMSCA 15 MG TABLET 10S, a specialty medication, with a period of performance ending on November 14, 2022. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB22D2206|SPE2DB25FGC74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SAMSCA 30 MG TABLET 10S. The contract has a firm fixed price, with a ceiling value of $44,091.96, and an ultimate completion date of April 4, 2025. The contract is a delivery order, not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $22,045.98 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets in quantities of 10 tablets per unit. This is a firm fixed-price delivery order with no set-aside designation, issued on September 17, 2025, with an ultimate completion date of October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- This delivery order, valued at $46,473.96, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a contract for SAMSCA 30 MG tablets through the Defense Logistics Agency. The contract is firm fixed-price with no set-aside designation, indicating it was awarded through full and open competition. The order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 17, 2026. SAMSCA (tolvaptan) is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,625.28 firm fixed-price delivery order covers the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care materials. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,585.99, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., worth up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.18 firm fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care materials. The award is part of a larger $999,999,999.00...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,322.83 firm fixed-price contract is for the delivery of various pharmaceutical products and medical supplies to support military and veterans' healthcare programs. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- The federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,143.74, is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and various medical devices and equipment. This contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,708.16 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which runs through November 2026. The contract provides for the delivery of a range of pharmaceutical products and medical supplies, including specialty...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT57RDelivery Order
The provided information details a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,269.78 firm fixed-price delivery order is for the supply of SAMSCA 15 MG TABLET 10S, a pharmaceutical product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating full and open competition. In addition to the DLA IDC, Cencora, Inc. also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 4/11/24 |